- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Molecular Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-04
DOI
10.3389/fnmol.2020.00137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease
- (2020) Sang Su Kwak et al. Nature Communications
- Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
- (2019) Christopher M. Henstridge et al. NATURE REVIEWS NEUROSCIENCE
- Recognition of the amyloid precursor protein by human γ-secretase
- (2019) Rui Zhou et al. SCIENCE
- Does intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein trigger early neurotoxicity in Alzheimer’s disease?
- (2019) I. Lauritzen et al. Current Alzheimer Research
- Pharmacokinetic and pharmacodynamic effects of a γ‐secretase modulator, PF‐06648671, on CSF amyloid‐β peptides in randomized Phase 1 studies
- (2019) Jae Eun Ahn et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP
- (2019) Laura García-González et al. Frontiers in Aging Neuroscience
- Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
- (2019) Miren Ettcheto et al. MOLECULAR NEUROBIOLOGY
- BACE1 partial deletion induces synaptic plasticity deficit in adult mice
- (2019) Sylvia Lombardo et al. Scientific Reports
- Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models
- (2019) Inger Lauritzen et al. Translational Neurodegeneration
- Unwinding of the Substrate Transmembrane Helix in Intramembrane Proteolysis
- (2018) Mia C. Brown et al. BIOPHYSICAL JOURNAL
- Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation
- (2018) Brian T. O’Neill et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals
- (2018) Heidi I. L. Jacobs et al. NATURE NEUROSCIENCE
- A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
- (2018) Joseph Park et al. NATURE NEUROSCIENCE
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice
- (2018) Ming-Hsuan Ou-Yang et al. Science Translational Medicine
- Coupled Transmembrane Substrate Docking and Helical Unwinding in Intramembrane Proteolysis of Amyloid Precursor Protein
- (2018) Nicolina Clemente et al. Scientific Reports
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- Structural basis of Notch recognition by human γ-secretase
- (2018) Guanghui Yang et al. NATURE
- Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP
- (2017) Eric Doran et al. JOURNAL OF ALZHEIMERS DISEASE
- BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides
- (2017) Kei Sakamoto et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Molecular Mechanism for the (−)-Epigallocatechin Gallate-Induced Toxic to Nontoxic Remodeling of Aβ Oligomers
- (2017) Rashik Ahmed et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Semagacestat Is a Pseudo-Inhibitor of γ-Secretase
- (2017) Shinji Tagami et al. Cell Reports
- NONCLINICAL PHARMACOLOGICAL CHARACTERIZATION OF THE BACE1 INHIBITOR LY3202626
- (2016) David L. McKinzie et al. Alzheimers & Dementia
- PF-06648671–A NOVEL GAMMA SECRETASE MODULATOR: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFECTS ON PLASMA AMYLOID-B LEVELS FOLLOWING SINGLE ORAL ASCENDING DOSES IN HEALTHY VOLUNTEERS
- (2016) Ruolun Qiu et al. Alzheimers & Dementia
- PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF LY3202626, A NOVEL BACE1 INHIBITOR, IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER’S DISEASE
- (2016) Brian A. Willis et al. Alzheimers & Dementia
- RESULTS FROM A FIRST-IN-HUMAN STUDY WITH THE BACE INHIBITOR CNP520
- (2016) Mike Ufer et al. Alzheimers & Dementia
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
- (2016) Susanna Eketjäll et al. JOURNAL OF ALZHEIMERS DISEASE
- Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors
- (2016) Rita Maria Concetta Di Martino et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease
- (2016) Jack D. Scott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model
- (2016) HUIMIN WANG et al. Molecular Medicine Reports
- Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
- (2016) Chengjie Xiong et al. NEUROLOGY
- Familial Alzheimer’s Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds
- (2016) Sarah Veugelen et al. NEURON
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Single oral doses of the novel bace inhibitor bi 1181181 significantly reduce concentrations of cerebrospinal fluid amyloid-beta peptides in healthy subjects
- (2015) Andreas Borta et al. Alzheimers & Dementia
- Pharmacokinetics, pharmacodynamics, and safety of the novel bace inhibitor bi1181181 after oral administration of single ascending doses in healthy subjects
- (2015) Laurent Nicolas et al. Alzheimers & Dementia
- Pharmacological characterization of the new bace1 inhibitor bi 1181181
- (2015) Cornelia Dorner-Ciossek et al. Alzheimers & Dementia
- Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
- (2015) K. G. Goozee et al. BRITISH JOURNAL OF NUTRITION
- The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A Pharmacodynamic Responses in Mice, Dogs, and Humans
- (2015) P. C. May et al. JOURNAL OF NEUROSCIENCE
- A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
- (2015) Ulf Neumann et al. Molecular Neurodegeneration
- Synthesis of BACE Inhibitor LY2886721. Part II. Isoxazolidines as Precursors to Chiral Aminothiazines, Selective Peptide Coupling, and a Controlled Reactive Crystallization
- (2015) Marvin M. Hansen et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Synthesis of BACE Inhibitor LY2886721. Part I. An Asymmetric Nitrone Cycloaddition Strategy
- (2015) Stanley P. Kolis et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH
- (2015) Shangyu Dang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sampling the conformational space of the catalytic subunit of human γ-secretase
- (2015) Xiao-chen Bai et al. eLife
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer’s disease amyloid-β peptides
- (2015) Xiling Lei et al. Scientific Reports
- CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
- (2014) Bruce Albala et al. Alzheimers & Dementia
- Estimating long-term multivariate progression from short-term data
- (2014) Michael C. Donohue et al. Alzheimers & Dementia
- A data-driven model of biomarker changes in sporadic Alzheimer's disease
- (2014) Alexandra L. Young et al. BRAIN
- Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism
- (2014) Ilie-Cosmin Stancu et al. Molecular Neurodegeneration
- Allosteric regulation of -secretase activity by a phenylimidazole-type -secretase modulator
- (2014) K. Takeo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Familial Alzheimer’s mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site
- (2014) Wen Chen et al. Nature Communications
- Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF
- (2013) Francois Bernier et al. Alzheimers & Dementia
- A fast growing spectrum of biological functions of γ-secretase in development and disease
- (2013) Nathalie Jurisch-Yaksi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
- (2013) Joel Ross et al. Current Alzheimer Research
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence for impaired amyloid β clearance in Alzheimer's disease
- (2013) Kristin R Wildsmith et al. Alzheimers Research & Therapy
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity
- (2012) Christina J. Crump et al. BIOCHEMISTRY
- Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers
- (2012) Gary Tong et al. CLINICAL THERAPEUTICS
- The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
- (2012) Lucía Chávez-Gutiérrez et al. EMBO JOURNAL
- Automatic Stochastic Arabic Spelling Correction With Emphasis on Space Insertions and Deletions
- (2012) Mohamed I. Alkanhal et al. IEEE Transactions on Audio Speech and Language Processing
- Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
- (2012) Fredrik Jeppsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Familial Frontotemporal Dementia-Associated Presenilin-1 c.548G>T Mutation Causes Decreased mRNA Expression and Reduced Presenilin Function in Knock-In Mice
- (2012) H. Watanabe et al. JOURNAL OF NEUROSCIENCE
- The -Secretase-Derived C-Terminal Fragment of APP, C99, But Not A , Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus
- (2012) I. Lauritzen et al. JOURNAL OF NEUROSCIENCE
- Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice
- (2012) Kathryn Rogers et al. Molecular Neurodegeneration
- Presenilin mediates neuroprotective functions of ephrinB and brain-derived neurotrophic factor and regulates ligand-induced internalization and metabolism of EphB2 and TrkB receptors
- (2012) Gael Barthet et al. NEUROBIOLOGY OF AGING
- The Novel BACE Inhibitor MK-8931 Dramatically Lowers CSF A Peptides in Healthy Subjects: Results from a Rising Single Dose Study (PL02.004)
- (2012) M. Forman et al. NEUROLOGY
- Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease
- (2012) Xianhai Huang et al. ACS Medicinal Chemistry Letters
- Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1
- (2011) Christina J. Crump et al. ACS Chemical Neuroscience
- Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease
- (2011) Kyle C. Wilcox et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1
- (2011) Yu Ohki et al. EMBO JOURNAL
- Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation
- (2011) Wen-Jun Shan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo
- (2011) Zhong-Yue Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Central and peripheral pharmacodynamic effects of BACE1 inhibition following oral administration of LY2811376 to PDAPP mice and beagle dog
- (2010) Patrick C. May et al. Alzheimers & Dementia
- Central and Peripheral Pharmacokinetic and Pharmacodynamic Effects of the β-site APP Cleavage Enzyme (BACE1) Inhibitor LY2811376 In Humans
- (2010) Ferenc Martenyi et al. Alzheimers & Dementia
- The worldwide societal costs of dementia: Estimates for 2009
- (2010) Anders Wimo et al. Alzheimers & Dementia
- The γ-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer’s Disease
- (2010) Annamaria Lanzillotta et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice
- (2010) Mary Wines-Samuelson et al. PLoS One
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Nonspecificity of Binding of γ-Secretase Modulators to the Amyloid Precursor Protein
- (2009) Andrew J. Beel et al. BIOCHEMISTRY
- Piperidine-derived γ-secretase modulators
- (2009) Adrian Hall et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
- (2009) BP Imbimbo et al. BRITISH JOURNAL OF PHARMACOLOGY
- -Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of -Carboxyl Terminal Fragment
- (2009) M. Takami et al. JOURNAL OF NEUROSCIENCE
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
- (2009) Guojun Bu NATURE REVIEWS NEUROSCIENCE
- Calcium hypothesis of Alzheimer’s disease
- (2009) Michael J. Berridge PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies
- (2009) J. O. Korbel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid Precursor Protein Trafficking, Processing, and Function
- (2008) Gopal Thinakaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Substrate-targeting γ-secretase modulators
- (2008) Thomas L. Kukar et al. NATURE
- Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor
- (2007) U. Iserloh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
- (2003) H. F. Dovey et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now